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Two papers in this issue of Cell Stem Cell have made a significant advance in solving one of the great
challenges of modern immunology—resurrecting thymus function through the induction of thymus epithelial
cells (TECs) by directed differentiation of human embryonic stem cells (hESCs).The thymus is a specialized immune
organ that provides an inductive environ-
ment for the generation of T cells. Intrigu-
ingly, the thymus also has the unique
feature of ongoing age-related atrophy
beginning very early in life, albeit after
cell-mediated immunity has been fully
established. With the ‘‘wear and tear’’
effects of aging on the T cell pool,
which are exacerbated by cytoreduction
through chemotherapy, radiation, and in-
fections such asHIV, there is an increased
propensity for opportunistic infections,
poor responses to vaccines, a higher inci-
dence and burden of cancer, and an
increased onset of autoimmune diseases
(Heng et al., 2010). Reestablishing thymus
function thus has enormous clinical
applications.
The two complementary papers by
Parent et al. (2013) and Sun et al. (2013)
in this issue of Cell Stem Cell tackled
this challenge through the in vitro genera-
tion of TECs by directed differentiation
of hESCs. They follow on from the
pioneering work of Lai and Jin (2009),
who used mouse ESCs to generate func-
tional TEC progenitors (TEPCs) capable of
fully reconstituting the mouse immune
system. However, it was not clear if similar
results could be obtained with hESCs
until now.
Both studies employed essentially
similar logic to recreate in vitro the devel-
opmental pathways involved in thymus
development in vivo. Using specific com-
binations of Wnt3A, Retinoic Acid, and
BMP4, as well as inhibitors of TGF-b and
canonical Wnt signaling, both induction
protocols converted pluripotent hESCs
to the definitive anterior foregut (Parent
protocol only), the (third) pharyngealpouch endoderm (PPE) (from which the
thymus is known to originate), or both,
and finally to FOXN1+ and EpCAM+
TEPCs (Figure 1) (Anderson et al., 2007).
Most importantly, Sun et al. were further
able to demonstrate the ability of the
transplanted cells to produce T cells
from human HSCs.
While the induced T cultures in both
studies were clearly heterogeneous, the
data are consistent with the presence of
thymic epithelial progenitor (or thymic
epithelial progenitor-like) cells. However,
it is important to note that there were no
distinct indicators reflecting either cortical
or medullary TEC phenotypes in culture.
The TECs also lacked expression of
mature markers, such as MHC class II or
AIRE, which are required for the appro-
priate selection and self-tolerance induc-
tion of T cells. The lack of clear definition
of TEPCs in these mixtures is a major
unresolved issue, but collectively the
data are consistent with at least some
cells being committed to the TEC lineage
or lineages, but only at a very immature
stage of development.
The next major challenge was thus to
establish the functional capacity of the
TEPCs, with the expectation that their
maturation would be promoted by
engagement with thymocytes in vivo.
Here the two studies diverged somewhat
in their approaches. In the Sun study,
the TEPCs were reaggregated with
human embryonic fibroblasts (HEFs) as
a source of mesenchymal support prior
to transplantation, reflecting the need for
multicellular interactions in this context.
The TEPC-HEFs transplanted into athy-
mic nudemicewere able tomature in vivo,
with expression of MHC class II and AIRE,Cell Stem Cell 1but the internal thymic structures re-
mained poorly defined. The TEPC-HEF
transplants supported the development
and export to the blood of mature func-
tional T cells; however, a major lineage
bias toward CD4+ T cells was observed.
Importantly, analysis of the immature cells
in the thymus 8–12 weeks posttransplan-
tation indicated a severe reduction
therein, suggesting that these thymuses
could not sustain T cell production.
One logical explanation for the defi-
ciencies both in thymus structure and
function and the incomplete restoration
of the peripheral T cell compartments is
suboptimal human-mouse xenogeneic
cellular and molecular interactions. In
this regard, a major feature of the Sun
publication was transplantation of the
TEPCs into human HSC reconstituted
(humanized) NOD/SCID mice. In this spe-
cies-matched context, they observed
similar proportions of mature CD4+ and
CD8+ T cells, and importantly, a signifi-
cant level of immature thymocytes,
suggesting robust recruitment of the
human hematopoietic T cell progenitors
into the TEPC graft and their prolonged
differentiation.
Using a similar TEPC reaggregated
transplantation protocol into nude mice,
but without exogenous fibroblast support
cells, Parent et al. also showed the devel-
opment of thymus-like structures. While
small, disorganized, and incapable of
sustaining prolonged T cell production,
the structures did offer better evidence
of differentiation of the TEPCs into both
cortical and medullary subtypes. Again it
is unclear whether these arose from
a common or distinct stem/progenitor.
There was also evidence of TEPC3, August 1, 2013 ª2013 Elsevier Inc. 135
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Figure 1. Parallel Developmental Sequences to Reach Thymic Epithelial Cells
To date, although highly promising, in vitro protocols using human ESCs have achieved TEC progenitor status—but full TEC maturation requires the multicellular
and complex molecular environment in vivo.
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II, TEC markers including chemokines for
attracting hematopoietic cells and the
Notch signaling ligand DLL4, essential
for inducing T cell commitment. Unfortu-
nately with this protocol there was no
AIRE expression in the TECs, which
would predispose to autoimmunity. How-
ever, the Parent study did provide a more
robust analysis of the T cells produced
including proof of a broad T cell receptor
(TCR) repertoire and functional capacity
with respect to direct CD3/TCR crosslink-
ing and alloresponses including rejection
of skin grafts. These responses were
generally not as robust as those of wild-
type mouse T cells, no doubt reflecting
the species mismatch.
Despite the caveats of cellular impreci-
sion and incomplete thymus formation,
these two papers represent a quantum
advance in the field. The ability to
generate even quasifunctional human
TEPCs capable of inducing T cell produc-
tion is a major milestone. It is certain to
catalyze the pursuit of a more functional
thymus that will sustain a diverse self-
tolerant T cell repertoire. Several unre-
solved questions remain. What accounts136 Cell Stem Cell 13, August 1, 2013 ª2013for the failure of the grafts to expand
significantly and be maintained (suggest-
ing that they lack capacity for self-
renewal)? Similarly, what is the phenotype
of in-vitro-derived TEPCs? Do they differ
in the adult? Is there a common progenitor
for the cortex and medulla? Given that the
transplanted TEPCswere heterogeneous,
what supplementary role do the non-
TEPCs play, such as the HOXA3-,
EYA1-, and SIX1-expressing cells, which
are linked to neural crest mesenchyme
(Manley and Capecchi, 1998; Soh et al.,
2009)? Finally, are the TEPCs the primary
target during aging and can they be
stimulated to induce endogenous thymus
regrowth?
Generating a new pool of T cells is a
great achievement, but maintaining them
in a state of responsiveness to foreign
antigens while preventing autoimmunity
is another story. These studies have thus
provided a potentially important piece in
the jigsaw puzzle for creating both thera-
peutic products and a means of inducing
thymus-based tolerance to them, via
complementary protocols for inducing
differentiation of the same hESC line
(Chidgey et al., 2008). Which of the twoElsevier Inc.approaches—de novo thymus production
from pluripotential stem cells or rejuvena-
tion of the in situ atrophic remnant—reach
clinical safety and functional efficacy first
remains an intriguing race. Game on.
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